𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Variceal ligation plus nadolol compared with ligation for prophylaxis of variceal rebleeding: A multicenter trial

✍ Scribed by Joaquin de la Peña; Enric Brullet; Eloy Sanchez-Hernández; Monserrat Rivero; Mercedes Vergara; Jose Luis Martin-Lorente; Covadonga Garcia Suárez

Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
123 KB
Volume
41
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

✦ Synopsis

beta-Blockers and endoscopic variceal ligation (EVL) have proven to be valuable methods in the prevention of variceal rebleeding. The aim of this study was to compare the efficacy of EVL combined with nadolol versus EVL alone as secondary prophylaxis for variceal bleeding. Patients admitted for acute variceal bleeding were treated during emergency endoscopy with EVL or sclerotherapy and received somatostatin for 5 days. At that point, patients were randomized to receive EVL plus nadolol or EVL alone. EVL sessions were repeated every 10 to 12 days until the varices were eradicated. Eighty patients with cirrhosis (alcoholic origin in 66%) were included (Child-Turcotte-Pugh A, 15%; B, 56%; C, 29%). The median follow-up period was 16 months (range, 1-24 months). The variceal bleeding recurrence rate was 14% in the EVL plus nadolol group and 38% in the EVL group (P = .006). Mortality was similar in both groups: five patients (11.6%) died in the combined therapy group and four patients (10.8%) died in the EVL group. There were no significant differences in the number of EVL sessions to eradicate varices: 3.2 +/- 1.3 in the combined therapy group versus 3.5 +/- 1.3 in the EVL alone group. The actuarial probability of variceal recurrence at 1 year was lower in the EVL plus nadolol group (54%) than in the EVL group (77%; P = .06). Adverse effects resulting from nadolol were observed in 11% of the patients. In conclusion, nadolol plus EVL reduces the incidence of variceal rebleeding compared with EVL alone. A combined treatment could lower the probability of variceal recurrence after eradication.

📜 SIMILAR VOLUMES

Controlled trial of ligation plus nadolo
Controlled trial of ligation plus nadolol versus nadolol alone for the prevention of first variceal bleeding
✍ Gin-Ho Lo; Wen-Chi Chen; Huay-Min Wang; Ching-Chang Lee 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 463 KB

Both nadolol and ligation have proved to be effective in the prophylaxis of first variceal bleeding. This study was conducted to evaluate the effects and safety of combining nadolol with ligation. Cirrhotic patients with high-risk esophageal varices but without a bleeding history were considered for

A randomized trial comparing transjugula
A randomized trial comparing transjugular intrahepatic portosystemic stent-shunt with variceal band ligation in the prevention of rebleeding from esophageal varices
✍ R Jalan; E H Forrest; A J Stanley; D N Redhead; J Forbes; J F Dillon; A J MacGil 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 204 KB 👁 2 views

The aim of this study was to compare transjugular intrahepatic portosystemic stent-shunt (TIPSS) with variceal band ligation (VBL) in the secondary prophylaxis of esophageal variceal hemorrhage in patients with cirrhosis. Fifty-eight patients with cirrhosis who presented with the first episode of es

A randomized study comparing ligation wi
A randomized study comparing ligation with propranolol for primary prophylaxis of variceal bleeding in candidates for liver transplantation
✍ Lorenzo Norberto; Lino Polese; Umberto Cillo; Francesco Grigoletto; Andrew K. Bu 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 149 KB 👁 1 views

Whether beta-blockers (BB) or banding is the best therapy for primary prophylaxis of variceal bleeding is subject to debate. A randomized comparison between the 2 treatments was performed in candidates for liver transplantation (LT). A total of 62 patients with Child-Turcotte-Pugh B-C cirrhosis and

Improved survival in patients receiving
Improved survival in patients receiving medical therapy as compared with banding ligation for the prevention of esophageal variceal rebleeding
✍ Gin-Ho Lo; Wen-Chi Chen; Chiun-Ku Lin; Wei-Lun Tsai; Hoi-Hung Chan; Tai-An Chen; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 287 KB 👁 2 views

Both medical therapy and endoscopic variceal ligation (EVL) have proven to be comparable in the prevention of variceal rebleeding. However, the long-term results are still lacking. Our previous study enrolled 121 patients with history of esophageal variceal bleeding and randomized to receive EVL (EV

Propranolol for prophylaxis of bleeding
Propranolol for prophylaxis of bleeding in cirrhotic patients with large varices: A multicenter, randomized clinical trial
📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 498 KB 👁 2 views

To assess if propranolol prevents the first bleeding in cirrhosis, we randomly assigned 174 patients with large varices to either propranolol in doses reducing the resting heart rate by 25% (85 patients) or to a placebo (oral vitamin K, 89 patients). Sixty-nine patients had alcoholic cirrhosis, 24 p